Phil McEwan
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Hepatology top 2%
- Hepatitis C virus research
Papers in
-
- Diabetes Treatment and Management 44
- Diabetes Management and Research 20
-
- Health Systems, Economic Evaluations, Quality of Life 30
- Pharmaceutical Economics and Policy 6
- Co-authors
- Craig J. Currie (19 shared papers)Klas Bergenheim (25 shared papers)Marc Evans (32 shared papers)Murray Krahn (2 shared papers)A. David Paltiel (2 shared papers)Louise B. Russell (2 shared papers)Mark S. Roberts (2 shared papers)Michael Chambers (2 shared papers)
- Journals
- Value in Health (51 papers)Current Medical Research and Opinion (12 papers)PharmacoEconomics (10 papers)Journal of Medical Economics (10 papers)Diabetes Obesity and Metabolism (10 papers)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Phil McEwan
197 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 134
- Endocrinology, Diabetes and Metabolism 1.5k
- Hepatology 362
- Family Practice 51
- Transplantation 70
- Cardiology and Cardiovascular Medicine 487
Countries citing papers authored by Phil McEwan
This map shows the geographic impact of Phil McEwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phil McEwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phil McEwan more than expected).
Fields of papers citing papers by Phil McEwan
This network shows the impact of papers produced by Phil McEwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phil McEwan. The network helps show where Phil McEwan may publish in the future.
Co-authors
The 25 scholars most cited alongside Phil McEwan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 208 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 307 | |
| 2 | 2006 | 244 | |
| 3 | 2008 | 218 | |
| 4 | 2014 | 189 | |
| 5 | 2014 | 186 | |
| 6 | 2012 | 167 | |
| 7 | 2021 | 127 | |
| 8 | 2020 | 100 | |
| 9 | 2009 | 100 | |
| 10 | 2015 | 99 | |
| 11 | 2019 | 91 | |
| 12 | 2005 | 84 | |
| 13 | 2005 | 73 | |
| 14 | 2005 | 71 | |
| 15 | 2004 | 70 | |
| 16 | 2020 | 69 | |
| 17 | 2013 | 65 | |
| 18 | 2019 | 63 | |
| 19 | 2019 | 56 | |
| 20 | 2017 | 54 |
About Phil McEwan
Phil McEwan is a scholar working on Endocrinology, Diabetes and Metabolism, Economics and Econometrics, Hepatology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, having authored 208 papers that have together received 4.7k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (44 papers), Health Systems, Economic Evaluations, Quality of Life (30 papers), Hepatitis C virus research (25 papers), Diabetes Management and Research (20 papers), Potassium and Related Disorders (15 papers), Atrial Fibrillation Management and Outcomes (7 papers), Heart Failure Treatment and Management (7 papers) and Pharmaceutical Economics and Policy (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.5k citations), Hepatology (362 citations), Family Practice (51 citations), Transplantation (70 citations) and Cardiology and Cardiovascular Medicine (487 citations). Phil McEwan has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Craig J. Currie, Klas Bergenheim, Marc Evans, Murray Krahn, A. David Paltiel, Louise B. Russell, Mark S. Roberts, Michael Chambers, Chris Poole and Adam Lloyd. Their work appears in journals such as Value in Health, Current Medical Research and Opinion, PharmacoEconomics, Journal of Medical Economics and Diabetes Obesity and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.